- ISIN
- KYG1117K1141
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- IPO Date
- Mar 22, 2018
Highlights
- Market Cap
- $24.14M
- Enterprise Value
- $427.04M
- EPS (TTM)
- -$3.84
- Total Revenue (TTM)
- $263.71M
- Gross Profit (TTM)
- $97.66M
- EBITDA (TTM)
- -$1.32M
- Year Range
- $0.35 - $5.00
- Target Price
- $2.00
- ROA (TTM)
- -45.99%
- ROE (TTM)
- -359.78%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BIOX Performance Chart
Bioceres Crop Solutions Corp. (BIOX) is down 71.0% since the beginning of the year. At $0 per share, BIOX is trading 92.4% below its 52-week high of $5. Investors who bought $1,000 worth of BIOX shares 5 years ago would now be looking at an investment worth $27.
Loading charts...
Returns By Period
Bioceres Crop Solutions Corp. (BIOX) has returned -71.02% so far this year and -91.64% over the past 12 months.
Bioceres Crop Solutions Corp.
- 1D
- 1.80%
- 1M
- -8.29%
- YTD
- -71.02%
- 6M
- -71.88%
- 1Y
- -91.64%
- 3Y*
- -69.77%
- 5Y*
- -51.48%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
BIOX Monthly Returns History
Based on dividend-adjusted daily data since Mar 22, 2018, BIOX's average daily return is -0.07%, while the average monthly return is -1.87%.
Historically, 43% of months were positive and 57% were negative. The best month was Apr 2021 with a return of +47.4%, while the worst month was Sep 2025 at -49.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 10 months.
On a daily basis, BIOX closed higher 43% of trading days. The best single day was Oct 15, 2025 with a return of +28.6%, while the worst single day was Mar 14, 2019 at -43.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -36.05% | -33.16% | -20.55% | 4.99% | -4.54% | -14.87% | -71.02% | ||||||
| 2025 | 12.66% | -41.31% | 13.56% | -6.90% | 14.82% | -8.40% | -23.49% | -18.42% | -49.46% | 43.97% | -15.27% | -23.84% | -78.45% |
| 2024 | -2.77% | -1.65% | -3.58% | -6.79% | -0.17% | -4.84% | -0.98% | -4.14% | -26.03% | -14.61% | 5.95% | -14.61% | -55.72% |
| 2023 | 3.91% | -7.76% | 0.69% | -3.45% | 6.42% | 11.99% | -3.52% | -4.97% | -7.84% | -2.21% | 10.51% | 12.54% | 14.13% |
| 2022 | -10.47% | -0.55% | 8.18% | 7.20% | 0.55% | -6.61% | -23.78% | 32.82% | -6.20% | 11.06% | -4.50% | -12.89% | -14.92% |
| 2021 | 14.68% | 15.33% | 24.15% | 47.35% | 2.40% | -8.53% | -0.50% | 0.07% | -3.50% | -4.07% | 15.98% | -5.86% | 128.06% |
Benchmark Metrics
Bioceres Crop Solutions Corp. has an annualized alpha of -23.42%, beta of 0.60, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since March 22, 2018.
- This stock participated in 129.18% of S&P 500 Index downside but only -35.15% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.60 may look defensive, but with R2 of 0.03 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -23.42%
- Beta
- 0.60
- R²
- 0.03
- Upside Capture
- -35.15%
- Downside Capture
- 129.18%
Return for Risk
Risk / Return Rank
BIOX ranks 5 for risk / return — in the bottom 5% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Bioceres Crop Solutions Corp. (BIOX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIOX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.93 | ||
| Sortino ratioReturn per unit of downside risk | -5.26 | ||
| Omega ratioGain probability vs. loss probability | 0.72 | 1.37 | -0.65 |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | 2.78 | -3.78 |
| Martin ratioReturn relative to average drawdown | -1.27 | 12.44 | -13.71 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Bioceres Crop Solutions Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Bioceres Crop Solutions Corp. was 97.68%, occurring on Mar 18, 2026. The portfolio has not yet recovered.
The current Bioceres Crop Solutions Corp. drawdown is 97.63%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -97.68%Mar 2026 | 4y 4mo | — | 4y 7moNov 2021 - now |
2019 bear market2019 | -59.41%May 2019 | 5mo 5d | 1y 10mo | 2y 3moDec 2018 - Mar 2021 |
2021 bear market2021 | -23.83%Jun 2021 | 28d | 5mo 4d | 6mo 2dMay 2021 - Nov 2021 |
2021 correction2021 | -12.51%Mar 2021 | 11d | 7d | 18dMar 2021 - Apr 2021 |
2021 correction2021 | -10.68%Apr 2021 | 2d | 14d | 16dApr 2021 - Apr 2021 |
Drawdown Indicators
| BIOX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.68% | -56.78% | -40.90% |
Max Drawdown (1Y)Largest decline over 1 year | -92.57% | -9.10% | -83.47% |
Max Drawdown (3Y)Largest decline over 3 years | -97.33% | -18.90% | -78.43% |
Max Drawdown (5Y)Largest decline over 5 years | -97.68% | -25.43% | -72.25% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -97.63% | -1.80% | -95.83% |
Average DrawdownAverage peak-to-trough decline | -36.42% | -10.71% | -25.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 72.19% | 2.03% | +70.16% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Bioceres Crop Solutions Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Bioceres Crop Solutions Corp. is priced in the market compared to other companies in the Agricultural Inputs industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BIOX relative to other companies in the Agricultural Inputs industry. Currently, BIOX has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for BIOX in comparison with other companies in the Agricultural Inputs industry. Currently, BIOX has a P/B value of 0.4. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with BIOX
Add Bioceres Crop Solutions Corp. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BIOX